AUPH Stock News: Robbins LLP Investigates Aurinia Pharmaceuticals Inc. (AUPH) on Behalf of Shareholders – Lawyer Monthly
[ad_1]
SAN DIEGO–(Business enterprise WIRE)–$AUPH #AuriniaPharmaceuticals–Shareholder legal rights regulation organization Robbins LLP is investigating Aurinia Prescription drugs Inc. (NASDAQ: AUPH) and its officers and directors to ascertain whether they breached their fiduciary obligations and violated securities guidelines relating to the financial effect of its drug LUPKYNIS. Aurinia is a biopharmaceutical company that develops and commercializes therapies to address conditions with unmet clinical need in Japan and the People’s Republic of China. LUPKYNIS is the Company’s only item, which it presents for the treatment method of grownup individuals with energetic lupus nephritis.
If you would like far more details about our investigation of Aurinia Prescription drugs Inc.’s misconduct, click on below.
What is this Situation About: In accordance to a complaint filed in opposition to Aurinia, throughout the class period, defendants unsuccessful to disclose that the Firm was dealing with declining revenues and that the 2022 sales outlook for LUPKYNIS would drop shorter of anticipations.
On February 28, 2022, Aurinia introduced its fiscal final results for the full quarter and full 12 months finished December 31, 2021, like a calendar year-over-year income decline and lower than predicted sales outlook for 2022. On this news, Aurinia’s inventory fell $3.94 for each share, or 24.26%, to shut at $12.30 for each share on February 28, 2022.
Up coming Ways: If you acquired shares of Aurinia Pharmaceuticals Inc. (AUPH) between Might 7, 2021 and February 26, 2022, you have lawful options. Conact us for extra facts.
All representation is on a contingency cost foundation. Shareholders pay out no service fees or costs.
Speak to us to master much more:
Aaron Dumas
(800) 350-6003
[email protected]
Shareholder Info Type
About Robbins LLP: A identified chief in shareholder legal rights litigation, the lawyers and team of Robbins LLP have been devoted to supporting shareholders recover losses, enhance company governance constructions, and maintain business executives accountable for their wrongdoing due to the fact 2002. To be notified if a course action versus Aurinia Pharmaceuticals Inc. settles or to get totally free alerts when corporate executives have interaction in wrongdoing, indication up for Inventory Observe nowadays.
Attorney Marketing. Previous success do not guarantee a related consequence.
Contacts
Aaron Dumas
Robbins LLP
5040 Shoreham Area
San Diego, CA 92122
[email protected]
(800) 350-6003
[ad_2]
Source connection